What will you learn?
The integration of high-throughput sequencing data in antibody screening accelerates and improves discovery of novel therapeutic antibodies. However, getting from millions of sequences to a diverse set of developable antibodies with the right therapeutic properties can be incredibly challenging, time-consuming, and requires significant software and computational resources. In this session, you will learn how to:
- Perform advanced clustering and phylogenetic analysis through an intuitive user interface
- De-risk antibody development by annotating structural liabilities for thousands of sequences at once
- Speed up candidate selection by exploring multiple antibody characteristics in a single visualization